Showing results (581-590 of 599) with videos related to
Sort By:
Pageof 60
Kidney International|January 18, 2013
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approachCrystal A Gadegbeku, Debbie S Gipson, Lawrence B Holzman, et al.Nature|May 10, 2023
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancerLuis A Rojas, Zachary Sethna, Kevin C Soares, et al.Clinical Kidney Journal|September 9, 2020
The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome Study NetworkJonathan P Troost, Anne Waldo, Noelle E Carlozzi, et al.Anesthesiology|August 4, 2018
Complications in Pediatric Regional Anesthesia: An Analysis of More than 100,000 Blocks from the Pediatric Regional Anesthesia NetworkBenjamin J Walker, Justin B Long, Madhankumar Sathyamoorthy, et al.American Journal of Epidemiology|June 17, 2024
The Study of the Epidemiology of Pediatric Hypertension Registry (SUPERHERO): rationale and methodsAndrew M South, Victoria C Giammattei, Kiri W Bagley, et al.Pediatric Nephrology (Berlin, Germany)|March 1, 2021
APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosisJarcy Zee, Michelle T McNulty, Jeffrey B Hodgin, et al.Molecular Psychiatry|August 9, 2006
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genesK Brookes, X Xu, W Chen, et al.Science Translational Medicine|January 14, 2026
Endothelial cell-released CD93 contributes to podocyte injury in idiopathic nephrotic syndromeColin Bauer, Federica Piani, Jonathan Troost, et al.Clinical Journal of the American Society of Nephrology : CJASN|December 15, 2015
Complete Remission in the Nephrotic Syndrome Study NetworkDebbie S Gipson, Jonathan P Troost, Richard A Lafayette, et al.Kidney International|November 28, 2022
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosisLaura H Mariani, Sean Eddy, Fadhl M AlAkwaa, et al.Pageof 60